Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
34.0%
% of FTXH's 51 holdings also in PJP
56.7%
% of PJP's 30 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 7.4% | 5.2% | 5.2% |
|
JOHNSON & JOHNSON | 7.5% | 5.1% | 5.1% |
|
MERCK & CO. INC. | 7.3% | 5.0% | 5.0% |
|
PFIZER INC | 7.2% | 4.9% | 4.9% |
|
AMGEN INC | 3.7% | 5.0% | 3.7% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to PJP
|
BRISTOL-MYERS SQUIBB CO | 4.7% |
|
ZOETIS INC | 3.7% |
|
ORGANON & CO. | 2.6% |
|
JOHNSON & JOHNSON | 2.4% |
|
PFIZER INC | 2.3% |
|
MERCK & CO. INC. | 2.2% |
|
ABBVIE INC | 2.2% |
|
CHARLES RIVER LABORATORIES | 2.0% |
|
EXELIXIS INC | 1.9% |
|
MEDPACE HOLDINGS, INC. | 1.8% |
FTXH Underweight Relative to PJP
|
ABBOTT LABORATORIES | -5.0% |
|
TARSUS PHARMACEUTICALS, INC. | -3.5% |
|
BIOSANTE PHARMACEUTICALS INC | -3.5% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.9% |
|
INNOVIVA, INC. | -2.8% |
|
PACIRA PHARMACEUTICALS INC | -2.8% |
|
SUPERNUS PHARMACEUTICALS INC | -2.8% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.7% |
|
TRAVERE THERAPEUTICS, INC. | -2.7% |
|
LIGAND PHARMACEUTICALS-CL B | -2.6% |